EUCAST proposes to change the definition and usefulness of the susceptibility category ‘Intermediate’-Reference-Cited by-同舟云学术

EUCAST proposes to change the definition and usefulness of the susceptibility category ‘Intermediate’

Published:2017-12 Issue:12 Volume:23 Page:894-895
ISSN:1198-743X
Container-title:Clinical Microbiology and Infection
language:en
Short-container-title:Clinical Microbiology and Infection

Author:

Kahlmeter G.

Publisher

Elsevier BV

Subject

Infectious Diseases,Microbiology (medical),General Medicine

Reference3 articles.

1. EUCAST European Committee on Antimicrobial Susceptibility Testing. Proposed modifications to EUCAST definition of the intermediate category,2016

2. European harmonization of MIC breakpoints for antimicrobial susceptibility testing of bacteria;Kahlmeter;J Antimicrob Chemother,2003

3. EUCAST European Committee on Antimicrobial Susceptibility Testing. Proposed modifications to EUCAST definition of the Intermediate category 2nd consultation,2017

Cited by 36 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Antimicrobial Resistance Patterns of Pathogens Isolated from Patients with Wound Infection at a Teaching Hospital in Vietnam;Infection and Drug Resistance;2024-08

2. EUCAST ciprofloxacin area of technical uncertainty in Escherichia coli and Klebsiella pneumoniae using BD Phoenix™ and VITEK® 2 automated susceptibility systems;Journal of Antimicrobial Chemotherapy;2024-07-16

3. Registry-Based Retrospective Cohort Study of Mortality among Adults Admitted to Intensive Care Units in Istanbul with Hospital Acquired Pseudomonas aeruginosa Bloodstream-Infection between 2014–2021;Antibiotics;2024-01-17

4. Cefoxitin versus carbapenems as definitive treatment for extended-spectrum β-lactamase-producing Klebsiella pneumoniae bacteremia in intensive care unit: a propensity-matched retrospective analysis;Critical Care;2023-11-01

5. Defining standard and high dosages for β-lactam agents administered by intermittent, prolonged or continuous infusion: a PK/PD simulation study;Journal of Antimicrobial Chemotherapy;2023-10-05